← Back to Clinical Trials
Recruiting NCT05740254

NCT05740254 Early vs. Late Time-Restricted Eating in Adolescents With Obesity (EL TREA)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05740254
Status Recruiting
Phase
Sponsor Children's Hospital Los Angeles
Condition Pediatric Obesity
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2023-03-27
Primary Completion 2026-01-01

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 21 Years
Study Type INTERVENTIONAL
Interventions
Early Time Restricted EatingLate Time Restricted Eating

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2023-03-27 with a primary completion date of 2026-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Determine the effectiveness of how limiting the time you eat within an early or late eating window and fasting for remainder of the day will impact weight loss and body mass index (BMI).

Eligibility Criteria

Inclusion Criteria: * 12-21 years with obesity (BMI\>95th percentile) * participant must be willing and able to adhere to the assessments, visit schedules, and eating/fasting periods * baseline eating window greater than 12 hours. Exclusion Criteria: * diagnosis of Prader-Willi Syndrome, brain tumor, or diabetes serious intellectual disability * previous diagnosis or subthreshold symptoms of an eating disorder (anorexia nervosa, bulimia nervosa, binge-eating disorder) * parent/guardian-reported physical, mental of other inability to participate in the assessments * previous bariatric surgery * current participation in other interventional weight loss studies.

Contact & Investigator

Central Contact

Alaina Vidmar, MD

✉ avidmar@chla.usc.edu

📞 323-361-4606

Principal Investigator

Alaina Vidmar, MD

PRINCIPAL INVESTIGATOR

Children's Hospital Los Angeles

Frequently Asked Questions

Who can join the NCT05740254 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 21 Years, studying Pediatric Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05740254 currently recruiting?

Yes, NCT05740254 is actively recruiting participants. Contact the research team at avidmar@chla.usc.edu for enrollment information.

Where is the NCT05740254 trial being conducted?

This trial is being conducted at Los Angeles, United States.

Who is sponsoring the NCT05740254 clinical trial?

NCT05740254 is sponsored by Children's Hospital Los Angeles. The principal investigator is Alaina Vidmar, MD at Children's Hospital Los Angeles. The trial plans to enroll 120 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology